Abstract:This study employed machine learning to identify and predict novel clusters in acute‐on‐chronic liver failure (ACLF), revealing four distinct clusters with varying trajectories, organ failures and survival rates. Clusters improved the accuracy of CLIF‐C‐ACLF. The findings offer insights into prognosis, trial recruitment, resource allocation and liver transplant decisions in ACLF. Summary Background and Aims Machine learning (ML) can identify the hidden patterns without hypothesis in heterogeneous diseases like acute‐on‐chronic live failure (ACLF). We employed ML to describe and predict yet unknown clusters in ACLF. Methods Clinical data of 1568 patients with ACLF from a tertiary care centre (2015–2023) were subjected to distance‐, density‐ and model‐based clustering algorithms. Final model was selected on best cluster separation, viz. Silhouette width and Dunn's index (for distance‐ or density‐based algorithms) and minimum BIC (for model‐based algorithms). Cluster assignments, patient trajectories and survival were analysed through inferential statistics. Supervised ML models were trained in 70% data that predicted clusters in remaining 30% data followed by an temporal validation. Results The cohort was male‐predominant (87%), aged 44.3 years, with alcohol‐associated hepatitis (62.9%) and survival of 50.5%. Due to poor performance of distance‐ and density‐based algorithms and better explainability, the latent class model (LCM) was selected for exploration. LCM revealed four clusters with distinct trajectories, reversibility and survival (independent of MELD, CLIF‐C ACLF and AARC scores). Cluster1 had patients with none/one organ failure and highest reversibility. Cluster2 had females with viral hepatitis and two organ failures. More‐than‐one acute precipitant, severity, infections, organ failures and irreversibility escalated from clusters 1 to 4. Circulatory and renal failures critically influenced cluster assignments. Incorporating clusters to CLIF‐C ACLF, infection and ACLF definition improved the discriminative accuracy of CLIF‐C‐ACLF by 11%. Extreme gradient boost and decision trees could predict clusters with AUCs of 0.989 (0.979–0.995) and 0.875 (0.865–0.890). MELD, CLIF‐C‐OF, haemoglobin, lactate, CLIF‐C‐ACLF and ALT were critical variables for cluster prediction. Clusters with distinct survival were documented in a temporal validation cohort. Conclusions ML for the first time could identify clusters with distinct phenotypes, trajectories and outcomes in ACLF. Stratification into clusters can address heterogeneity, guide prognosis, recruitment in trials, resource allocation and liver transplant discussions in ACLF.

Characterizing multimorbidity in ALIVE: Comparing single and ensemble clustering methods

Identifying Comorbidity Patterns in People with and without Alzheimer's Disease Using Latent Dirichlet Allocation

Multimorbidity in middle-aged women and COVID-19: binary data clustering for unsupervised binning of rare multimorbidity features and predictive modeling

A Call for Caution When Using Network Methods to Study Multimorbidity: An Illustration Using Data from the Canadian Longitudinal Study on Aging (CLSA)

Combining multimorbidity clustering with limited demographic information enables high-precision outcome predictions

Mapping multimorbidity progression among 190 diseases

Multimorbidity and mortality: A data science perspective

Subgrouping multimorbid patients with ischemic heart disease by means of unsupervised clustering: A cohort study of 72,249 patients defined by 3,046 diagnoses

Comorbidity Patterns among People Living with HIV: a Hierarchical Clustering Approach Through Integrated Electronic Health Records Data in South Carolina

Identifying and evaluating clinical subtypes of Alzheimer’s disease in care electronic health records using unsupervised machine learning

Unraveling the multiple chronic conditions patterns among people with Alzheimer's disease and related dementia: A machine learning approach to incorporate synergistic interactions

Unsupervised machine learning and prognostic factors of survival in chronic lymphocytic leukemia

Identifying frailty‐related clusters of Alzheimer’s and Vascular dementia: A multi‐modal data approach

Longitudinal clustering of health behaviours and their association with multimorbidity in older adults in England: A latent class analysis

Probabilistic Clustering using Shared Latent Variable Model for Assessing Alzheimers Disease Biomarkers

Joint model-based clustering of nonlinear longitudinal trajectories and associated time-to-event data analysis, linked by latent class membership: with application to AIDS clinical studies

What Can We Learn from Multimorbidity? A Deep Dive from Its Risk Patterns to the Corresponding Patient Profiles

Using clustering of genetic variants in Mendelian randomization to interrogate the causal pathways underlying multimorbidity from a common risk factor

Machine-learning based subgroups of AL amyloidosis and cumulative incidence of mortality and end stage kidney disease

Identification of four novel acute‐on‐chronic liver failure clusters with distinct clinical trajectories and mortality using machine learning methods